UNC Lineberger Comprehensive Cancer Center: Colorectal Neoplasms trials

The registry lists 17 Colorectal Neoplasms studies with UNC Lineberger Comprehensive Cancer Center as lead sponsor. 2 are open to participants now and 3 have results posted.

Phase 1 3Phase 2 1No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and SurvivalRecruitingNCT06896162Not applicable
• The PharmFIT StudyNot yet recruitingNCT06656936Not applicable
• Feasibility Testing of Patient Reported Outcomes - Informed Symptom Management System (PRISMS)CompletedNCT04492007Not applicableResults posted
• Scaling CRC Screening Through Outreach, Referral, and Engagement (SCORE)CompletedNCT04406714Not applicableResults posted
• Regorafenib+FOLFIRI Versus Placebo+FOLFIRI as 2nd Line Tx in Metastatic Colorectal CancerCompletedNCT01298570Phase 2Results posted
• mPATH-Cloud for Colorectal Cancer ScreeningActive, not recruitingNCT06441487Not applicable
• Physical Activity Centers EmpowermentCompletedNCT06411756Not applicable
• The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer TreatmentCompletedNCT06096623
• A Culturally-adapted Colorectal Cancer Screening Decision Aid Designed for American IndiansCompletedNCT03569761Not applicable
• Mailed Reminders Plus Fecal Immunochemical TestingCompletedNCT03176082Not applicable
• A Patient Portal Tool, E-assist, for Supporting CRC ScreeningCompletedNCT02798224Not applicable
• Physical Activity Intervention for Older Patients During Chemotherapy for Colorectal CancerCompletedNCT02191969Not applicable
• Effect of Curcumin on Dose Limiting Toxicity and Pharmacokinetics of Irinotecan in Patients With Solid TumorsCompletedNCT01859858Phase 1
• BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic CancerCompletedNCT01571024Phase 1
• Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination ChemotherapyCompletedNCT01164215Phase 1
• Fludeoxyglucose F 18-PET Imaging for Early Detection of Residual Disease in Patients Undergoing Radiofrequency Ablation of Liver Metastases From Colorectal CancerCompletedNCT00499395Not applicable
• Biomarkers in Patients With Rectal Cancer Undergoing Chemotherapy and Radiation TherapyCompletedNCT00280761